<img src="https://www.moneycontrol.com/news_image_files/2017/200x200/b/buy1_200.jpg" alt="Buy Sun Pharmaceuticals; target of Rs 530: Dolat Capital" title="Buy Sun Pharmaceuticals; target of Rs 530: Dolat Capital" border="0" width="75" height="75" align=" left" hspace="5"/> Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 530 in its research report dated May 27, 2020.